In addition to their monthly report, your patients will receive this month’s edition of our patient newsletter, Insights. This month covers the following:
- Notal Vision Monitoring Center name change
- New patient engagement touch points
- Understanding your ForeseeHome invoice
The patient’s monthly report includes their alerts from the previous month (if any), number of tests completed per eye, and a reminder about testing compliance.
Patient report information is also available to you via the ECP Portal. If you haven’t received your Portal login or are unable to log in, please contact us at practiceengagement@notalvision.com or 855-600-3112.
Related News
View Latest News
Referring Patients: Ideal Patients for ForeseeHome
November 2021
ForeseeHome is appropriate for the types of patients you see every day, specifically those with unilateral or bilateral intermediate dry AMD, or wet AMD in one eye and intermediate dry AMD in their fellow eye.
Referring Patients: Necessary Patient Information
November 2021
Help your patients start protecting their vision as soon as possible and avoid unnecessary insurance challenges by completing the ForeseeHome Order Form in its entirety.
What Is Considered Off-Label Use
November 2021
ForeseeHome is cleared by the FDA for the monitoring of patients with intermediate dry AMD, who we know are at risk of conversion to wet AMD.
